ALLERGY IMMUNO TECHNOLOGIES INC
10SB12G/A, EX-27, 2000-06-12
MEDICAL LABORATORIES
Previous: ALLERGY IMMUNO TECHNOLOGIES INC, 10SB12G/A, EX-23.1, 2000-06-12
Next: ALLERGY IMMUNO TECHNOLOGIES INC, 10QSB/A, 2000-06-12



<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          MAY-31-2000
<PERIOD-START>                             JUN-01-1999
<PERIOD-END>                               NOV-30-1999
<CASH>                                               0
<SECURITIES>                                         0
<RECEIVABLES>                                   20,950
<ALLOWANCES>                                    11,185
<INVENTORY>                                      6,456
<CURRENT-ASSETS>                                18,293
<PP&E>                                          46,582
<DEPRECIATION>                                  45,086
<TOTAL-ASSETS>                                  78,173
<CURRENT-LIABILITIES>                          205,532
<BONDS>                                              0
                                0
                                          0
<COMMON>                                        17,170
<OTHER-SE>                                   (144,529)
<TOTAL-LIABILITY-AND-EQUITY>                    78,173
<SALES>                                         43,591
<TOTAL-REVENUES>                                43,591
<CGS>                                           42,057
<TOTAL-COSTS>                                   42,057
<OTHER-EXPENSES>                                97,011
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                               (94,883)
<INCOME-TAX>                                       800
<INCOME-CONTINUING>                           (95,683)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (95,683)
<EPS-BASIC>                                      (.01)
<EPS-DILUTED>                                    (.01)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission